(Q37089685)

English

Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibi

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibi (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Norihiro Nishimoto

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Nobuyuki Miyasaka

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Kazuhiko Yamamoto

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Shinichi Kawai

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Tsutomu Takeuchi

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Junichi Azuma

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Tadamitsu Kishimoto

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

publication date

1 November 2008

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Modern Rheumatology

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

19

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

12-19

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638601

29 September 2017

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638601

29 September 2017

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638601

29 September 2017

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638601

29 September 2017

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638601

29 September 2017

Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638601

29 September 2017

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638601

29 September 2017

Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638601

29 September 2017

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638601

3 September 2018

Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638601

3 September 2018

Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2638601

3 September 2018

Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular permeability factor, an endothelial cell mitogen related to PDGF

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenesis: a critical process in the pathogenesis of RA--a role for VEGF?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3109/S10165-008-0125-1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37089685&oldid=2088589653"